Edwards Lifesciences Corporation (EW) Share buybacks
- Total buybacks · last 12 months (USD): Value $1.20B; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2026-06-30..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2026-06-30..
Share buybacks
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $1.20B | Trailing-year cash paid for share repurchases. Period ending 2026-06-30. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 1.20B USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2026-06-30 | $1.20B | (m) | (m) |
| 2026-03-31 | $1.06B | (m) | (m) |
| 2025-12-31 | $893.40M | (m) | (m) |
| 2025-09-30 | $952.90M | (m) | (m) |
| 2025-06-30 | $1.27B | (m) | (m) |
| 2025-03-31 | $1.42B | (m) | (m) |
| 2024-12-31 | $1.16B | (m) | (m) |
| 2024-09-30 | $1.51B | (m) | (m) |
| 2024-06-30 | $781.10M | (m) | (m) |
| 2024-03-31 | $630.50M | (m) | (m) |
| 2023-12-31 | $879.60M | (m) | (m) |
| 2023-09-30 | $1.30B | (m) | (m) |
| 2023-06-30 | $1.22B | (m) | (m) |
| 2023-03-31 | $1.57B | (m) | (m) |
| 2022-12-31 | $1.73B | (m) | (m) |
| 2022-09-30 | $957.60M | (m) | (m) |
| 2022-06-30 | $859.00M | (m) | (m) |
| 2022-03-31 | $615.80M | (m) | (m) |
| 2021-12-31 | $512.80M | (m) | (m) |
| 2021-09-30 | $416.50M | (m) | (m) |
| 2021-06-30 | $416.10M | (m) | (m) |
| 2021-03-31 | $313.20M | (m) | (m) |
| 2020-12-31 | $625.40M | (m) | (m) |
| 2020-09-30 | $625.20M | (m) | (m) |
| 2020-06-30 | $625.10M | (m) | (m) |
| 2020-03-31 | $872.40M | (m) | (m) |
| 2019-12-31 | $263.30M | (m) | (m) |
| 2019-09-30 | $535.30M | (m) | (m) |
| 2019-06-30 | $707.10M | (m) | (m) |
| 2019-03-31 | $799.10M | (m) | (m) |
| 2018-12-31 | $795.50M | (m) | (m) |
| 2018-09-30 | $774.80M | (m) | (m) |
| 2018-06-30 | $602.50M | (m) | (m) |
| 2018-03-31 | $328.10M | (m) | (m) |
| 2017-12-31 | $763.30M | (m) | (m) |
| 2017-09-30 | $793.40M | (m) | (m) |
| 2017-06-30 | $792.80M | (m) | (m) |
| 2017-03-31 | $755.60M | (m) | (m) |
| 2016-12-31 | $662.30M | (m) | (m) |
| 2016-09-30 | $480.90M | (m) | (m) |
| 2016-06-30 | $480.90M | (m) | (m) |
| 2016-03-31 | $523.20M | (m) | (m) |
| 2015-12-31 | $280.10M | (m) | (m) |
| 2015-09-30 | $180.30M | (m) | (m) |
| 2015-06-30 | $180.20M | (m) | (m) |
| 2015-03-31 | $101.90M | (m) | (m) |
| 2014-12-31 | $300.90M | (m) | (m) |
| 2014-09-30 | $323.40M | (m) | (m) |
| 2014-06-30 | $550.90M | (m) | (m) |
| 2014-03-31 | $689.20M | (m) | (m) |
| 2013-12-31 | $496.90M | (m) | (m) |
| 2013-09-30 | $652.00M | (m) | (m) |
| 2013-06-30 | $447.50M | (m) | (m) |
| 2013-03-31 | $362.30M | (m) | (m) |
| 2012-12-31 | $344.10M | (m) | (m) |
| 2012-09-30 | $206.40M | (m) | (m) |
| 2012-06-30 | $287.60M | (m) | (m) |
| 2012-03-31 | $317.10M | (m) | (m) |
| 2011-12-31 | $303.40M | (m) | (m) |
| 2011-09-30 | $263.30M | (m) | (m) |
| 2011-06-30 | $159.70M | (m) | (m) |
| 2011-03-31 | $177.80M | (m) | (m) |
| 2010-12-31 | $200.00M | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) |
| 2009-12-31 | $95.50M | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) |
| 2008-12-31 | $306.50M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |